Latest Episodes

Leaders in science join us to bring you valuable insights into the world of biotechnology. Subscribe and never miss an episode.

Latest Episodes

Chris Moxham - Part 3: Embracing Startup Life & Leveraging AI & Genetics in Drug Development

Embracing the Startup Challenge | Mastering Science-to-Business Communication | Building a Scalable Discovery Engine | Leveraging AI & Genetics in Drug Development

Chris Moxham - Part 2: From Eli Lilly Recruit to Building a $20M NYC Lab

From Eli Lilly Recruit to NYC Lab Builder | Leading High-Stakes Drug Discovery | Pioneering Quantitative Biology | "Making the Trains Run on Time"

Chris Moxham - Part 1: A Researcher's Journey from Long Island to Big

From Long Island to Biotech Pioneer | Cornell's Pivotal Role in Research Passion | Strategic Leap to Pharma Industry | Cultivating Effective Leadership in Science

Michael Chen - Part 2: Forging a Path from Chemistry PhD to Biotech CEO

From Grad Student to Biotech CEO | Unique Challenges Combining Science & Business | Developing Breakthrough Products | Building Partnerships with Big Pharma | Creating a Biotech GTM Strategy

Michael Chen - Part 1: Lessons in Resilience Learned as a Researcher

Influence of a Data-Driven Family | Do the Dishes in a Lab | NIH-Oxford Cambridge Scholarship Program | What Got Us Here Won’t Get Us There

Neela Patel - Part 4: From Big Pharma to Biotech Leadership in Oncology

Transitioning to Seattle Genetics & Business Development | Insights from Roche’s Acquisition | Building a Transformative Oncology Pipeline with Bonum Therapeutics

Neela Patel - Part 3: A Scientist's Role in Search & Evaluation & Corporate Development

Developing Pipeline Strategy at Poniard Pharmaceuticals | Business & Corporate Development in Oncology | Transitioning from Abbott to AbbVie to Seagen

Neela Patel | Part 2: The Value of Personal Relationships in the Lab

Leading an Academic Microbiology Lab | The Value of Personal Relationships in the Workplace | Leading a Team & Learning on the Job | The Volatility of an Acquisition